Anti-Cancer Drugs Journal Issues Research Articles in November 2022 Edition
October 25, 2022
October 25, 2022
LONDON, England, Oct. 25 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles on the following topics in its November 2022 edition:
Review Article:
* The effect of angiotensin receptor blockers and angiotensin-converting enzyme inhibi . . .
Review Article:
* The effect of angiotensin receptor blockers and angiotensin-converting enzyme inhibi . . .